PineTree Therapeutics
Engages in the development of disruptive therapies in Oncology and Immuno-oncology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor investor | €0.0 | round | |
* | $17.0m Valuation: $118m | Series A | |
| Total Funding | 000k | ||
Related Content
PineTree Therapeutics Inc. is a preclinical stage biotechnology company focused on developing groundbreaking therapies for cancer and infectious diseases. Based in Cambridge, PineTree Therapeutics is at the forefront of creating biologic treatments, which are therapies derived from living organisms. The company primarily serves patients suffering from various types of cancers and infectious diseases, aiming to address unmet medical needs in these areas.
PineTree Therapeutics operates in the biotechnology sector, specifically targeting oncology (cancer treatment) and virology (study of viruses and viral diseases). The company’s innovative approach includes the development of bispecific antibodies (bsAbs) through its proprietary TAER TAB technology. Bispecific antibodies are engineered proteins that can bind to two different types of antigens (targets), making them highly effective in targeting cancer cells. This technology is designed to attack a unique receptor found on cancer cells in multiple types of cancers, including lung, breast, pancreatic, cervical, colon, kidney, ovarian, and stomach cancers.
The company's business model revolves around drug discovery and development. PineTree Therapeutics generates revenue through partnerships, licensing agreements, and eventually, the commercialization of its therapies. By collaborating with other pharmaceutical companies and research institutions, PineTree Therapeutics can advance its drug candidates through clinical trials and bring them to market.
PineTree Therapeutics boasts a team of experienced scientific and business leaders with a proven track record in drug discovery, development, and commercialization. This expertise positions the company well to navigate the complex landscape of biotechnology and deliver innovative treatments to patients in need.
In summary, PineTree Therapeutics Inc. is a pioneering biotech firm developing advanced therapies for cancer and infectious diseases, leveraging its unique bispecific antibody technology to target hard-to-reach cancer cells.
Keywords: Biotechnology, Oncology, Infectious Diseases, Bispecific Antibodies, Cancer Treatment, Drug Discovery, Biologic Therapeutics, Preclinical Stage, Cambridge, Innovative Therapies.